Sign In

Login

Password

Forgot Password ? Sign Up

Opaganib (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Opaganib" in English language version.

refsWebsite
Global rank English rank
6nih.gov
4th place
4th place
3doi.org
2nd place
2nd place
1medscape.com
719th place
636th place

doi.org (Global: 2nd place; English: 2nd place)

  • Smith CD, Maines LW, Keller SN, Katz Ben-Yair V, Fathi R, Plasse TF, Levitt ML (2022). "Recent Progress in the Development of Opaganib for the Treatment of Covid-19". Drug Design, Development and Therapy. 16: 2199–2211. doi:10.2147/DDDT.S367612. PMC 9288228. PMID 35855741.
  • Camp ER, Patterson LD, Kester M, Voelkel-Johnson C (September 2017). "Therapeutic implications of bioactive sphingolipids: A focus on colorectal cancer". Cancer Biology & Therapy. 18 (9): 640–650. doi:10.1080/15384047.2017.1345396. PMC 5663409. PMID 28686076.
  • Lewis CS, Voelkel-Johnson C, Smith CD (2018). "Targeting Sphingosine Kinases for the Treatment of Cancer". Advances in Cancer Research. 140: 295–325. doi:10.1016/bs.acr.2018.04.015. ISBN 9780128142233. PMC 6447312. PMID 30060814.

medscape.com (Global: 719th place; English: 636th place)

emedicine.medscape.com

nih.gov (Global: 4th place; English: 4th place)

ncbi.nlm.nih.gov

  • Smith CD, Maines LW, Keller SN, Katz Ben-Yair V, Fathi R, Plasse TF, Levitt ML (2022). "Recent Progress in the Development of Opaganib for the Treatment of Covid-19". Drug Design, Development and Therapy. 16: 2199–2211. doi:10.2147/DDDT.S367612. PMC 9288228. PMID 35855741.
  • Camp ER, Patterson LD, Kester M, Voelkel-Johnson C (September 2017). "Therapeutic implications of bioactive sphingolipids: A focus on colorectal cancer". Cancer Biology & Therapy. 18 (9): 640–650. doi:10.1080/15384047.2017.1345396. PMC 5663409. PMID 28686076.
  • Lewis CS, Voelkel-Johnson C, Smith CD (2018). "Targeting Sphingosine Kinases for the Treatment of Cancer". Advances in Cancer Research. 140: 295–325. doi:10.1016/bs.acr.2018.04.015. ISBN 9780128142233. PMC 6447312. PMID 30060814.

pubmed.ncbi.nlm.nih.gov

  • Smith CD, Maines LW, Keller SN, Katz Ben-Yair V, Fathi R, Plasse TF, Levitt ML (2022). "Recent Progress in the Development of Opaganib for the Treatment of Covid-19". Drug Design, Development and Therapy. 16: 2199–2211. doi:10.2147/DDDT.S367612. PMC 9288228. PMID 35855741.
  • Camp ER, Patterson LD, Kester M, Voelkel-Johnson C (September 2017). "Therapeutic implications of bioactive sphingolipids: A focus on colorectal cancer". Cancer Biology & Therapy. 18 (9): 640–650. doi:10.1080/15384047.2017.1345396. PMC 5663409. PMID 28686076.
  • Lewis CS, Voelkel-Johnson C, Smith CD (2018). "Targeting Sphingosine Kinases for the Treatment of Cancer". Advances in Cancer Research. 140: 295–325. doi:10.1016/bs.acr.2018.04.015. ISBN 9780128142233. PMC 6447312. PMID 30060814.